Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 183

1.

Resveratrol Protects β amyloid-Induced Oxidative Damage and Memory Associated Proteins in H19-7 Hippocampal Neuronal Cells.

Rege SD, Geetha T, Broderick TL, Babu JR.

Curr Alzheimer Res. 2015 Feb 4. [Epub ahead of print]

PMID:
25654502
[PubMed - as supplied by publisher]
2.

Lifespan and healthspan extension by resveratrol.

Bhullar KS, Hubbard BP.

Biochim Biophys Acta. 2015 Jan 29. pii: S0925-4439(15)00021-6. doi: 10.1016/j.bbadis.2015.01.012. [Epub ahead of print] Review.

PMID:
25640851
[PubMed - as supplied by publisher]
3.

The Resveratrol Trimer Miyabenol C Inhibits β-Secretase Activity and β-Amyloid Generation.

Hu J, Lin T, Gao Y, Xu J, Jiang C, Wang G, Bu G, Xu H, Chen H, Zhang YW.

PLoS One. 2015 Jan 28;10(1):e0115973. doi: 10.1371/journal.pone.0115973. eCollection 2015.

PMID:
25629409
[PubMed - in process]
Free PMC Article
4.

Brazilin inhibits amyloid β-protein fibrillogenesis, remodels amyloid fibrils and reduces amyloid cytotoxicity.

Du WJ, Guo JJ, Gao MT, Hu SQ, Dong XY, Han YF, Liu FF, Jiang S, Sun Y.

Sci Rep. 2015 Jan 23;5:7992. doi: 10.1038/srep07992.

PMID:
25613018
[PubMed - in process]
Free PMC Article
5.
6.

Mutational analysis of the ability of resveratrol to inhibit amyloid formation by islet amyloid polypeptide: critical evaluation of the importance of aromatic-inhibitor and histidine-inhibitor interactions.

Tu LH, Young LM, Wong AG, Ashcroft AE, Radford SE, Raleigh DP.

Biochemistry. 2015 Jan 27;54(3):666-76. doi: 10.1021/bi501016r. Epub 2015 Jan 15.

PMID:
25531836
[PubMed - in process]
7.

Resveratrol as a therapeutic agent for Alzheimer's disease.

Ma T, Tan MS, Yu JT, Tan L.

Biomed Res Int. 2014;2014:350516. doi: 10.1155/2014/350516. Epub 2014 Nov 26.

PMID:
25525597
[PubMed - in process]
Free PMC Article
8.

AMPK-Dependent Autophagic Activation Is Probably Involved in the Mechanism of Resveratrol Exerting Therapeutic Effects for Alzheimer's Disease.

Wang ZG, Yang C, Zhu B, Hua F.

Rejuvenation Res. 2015 Feb;18(1):101-2. doi: 10.1089/rej.2014.1652. No abstract available.

PMID:
25496421
[PubMed - in process]
9.

Capping of aβ42 oligomers by small molecule inhibitors.

Fu Z, Aucoin D, Ahmed M, Ziliox M, Van Nostrand WE, Smith SO.

Biochemistry. 2014 Dec 23;53(50):7893-903. doi: 10.1021/bi500910b. Epub 2014 Dec 11.

PMID:
25422864
[PubMed - in process]
10.

Nutraceuticals and amyloid neurodegenerative diseases: a focus on natural phenols.

Rigacci S, Stefani M.

Expert Rev Neurother. 2015 Jan;15(1):41-52. doi: 10.1586/14737175.2015.986101. Epub 2014 Nov 24.

PMID:
25418871
[PubMed - in process]
11.

Possible role of resveratrol targeting estradiol and neprilysin pathways in lipopolysaccharide model of Alzheimer disease.

El-Sayed NS, Bayan Y.

Adv Exp Med Biol. 2015;822:107-18. doi: 10.1007/978-3-319-08927-0_12.

PMID:
25416980
[PubMed - in process]
12.

Roles of resveratrol and other grape-derived polyphenols in Alzheimer's disease prevention and treatment.

Pasinetti GM, Wang J, Ho L, Zhao W, Dubner L.

Biochim Biophys Acta. 2014 Oct 12. pii: S0925-4439(14)00312-3. doi: 10.1016/j.bbadis.2014.10.006. [Epub ahead of print]

PMID:
25315300
[PubMed - as supplied by publisher]
13.

Neuroprotective effects of resveratrol in Alzheimer disease pathology.

Rege SD, Geetha T, Griffin GD, Broderick TL, Babu JR.

Front Aging Neurosci. 2014 Sep 11;6:218. doi: 10.3389/fnagi.2014.00218. eCollection 2014. Review.

PMID:
25309423
[PubMed]
Free PMC Article
14.

Interaction of Aβ(25-35) fibrillation products with mitochondria: Effect of small-molecule natural products.

Ghobeh M, Ahmadian S, Meratan AA, Ebrahim-Habibi A, Ghasemi A, Shafizadeh M, Nemat-Gorgani M.

Biopolymers. 2014 Nov;102(6):473-86. doi: 10.1002/bip.22572.

PMID:
25297917
[PubMed - in process]
15.

Alzheimer's disease and epigenetic diet.

Sezgin Z, Dincer Y.

Neurochem Int. 2014 Dec;78:105-16. doi: 10.1016/j.neuint.2014.09.012. Epub 2014 Oct 5.

PMID:
25290336
[PubMed - in process]
16.

Neuroprotective action of resveratrol.

Bastianetto S, Ménard C, Quirion R.

Biochim Biophys Acta. 2014 Oct 2. pii: S0925-4439(14)00292-0. doi: 10.1016/j.bbadis.2014.09.011. [Epub ahead of print] Review.

PMID:
25281824
[PubMed - as supplied by publisher]
17.

Novel resveratrol analogues attenuate renal ischemic injury in rats.

Khader A, Yang WL, Kuncewitch M, Prince JM, Marambaud P, Nicastro J, Coppa GF, Wang P.

J Surg Res. 2015 Feb;193(2):807-15. doi: 10.1016/j.jss.2014.08.015. Epub 2014 Aug 13.

PMID:
25214260
[PubMed - indexed for MEDLINE]
18.

Resveratrol improves cognition and reduces oxidative stress in rats with vascular dementia.

Ma X, Sun Z, Liu Y, Jia Y, Zhang B, Zhang J.

Neural Regen Res. 2013 Aug 5;8(22):2050-9. doi: 10.3969/j.issn.1673-5374.2013.22.004.

PMID:
25206513
[PubMed]
Free PMC Article
19.

Neuroprotective role of trans-resveratrol in a murine model of familial Alzheimer's disease.

Porquet D, Griñán-Ferré C, Ferrer I, Camins A, Sanfeliu C, Del Valle J, Pallàs M.

J Alzheimers Dis. 2014;42(4):1209-20. doi: 10.3233/JAD-140444.

PMID:
25024312
[PubMed - in process]
20.

Supplemental substances derived from foods as adjunctive therapeutic agents for treatment of neurodegenerative diseases and disorders.

Bigford GE, Del Rossi G.

Adv Nutr. 2014 Jul 14;5(4):394-403. doi: 10.3945/an.113.005264. Print 2014 Jul. Review.

PMID:
25022989
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk